Bridgeway Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-12,100
Closed -$523K 1279
2019
Q4
$523K Sell
12,100
-1,500
-11% -$61.1K 0.01% 967
2019
Q3
$492K Buy
+13,600
New +$573K 0.01% 965

Other funds holding ATEX

Bridgeway Capital Management's ATEX Position: Q1 2020 in Review

Bridgeway Capital Management sold out of Anterix (ATEX) in Q1 2020, closing a stake of 12,100 shares — an estimated $523K sold.

Bridgeway Capital Management first reported a position in ATEX in Q3 2019 and held it in 2 quarters. The position peaked at $523K in Q4 2019. 84 funds tracked by Wall St. Rank hold ATEX as of Q1 2020.

  • Bridgeway Capital Management reported no remaining Anterix position as of Q1 2020 after selling out during the quarter.
  • Bridgeway Capital Management sold 12,100 Anterix shares in Q1 2020, an estimated $523K.
  • Bridgeway Capital Management first reported a position in Anterix in Q3 2019 and held it in 2 quarters.
  • Bridgeway Capital Management's Anterix position peaked at $523K in Q4 2019.
  • 84 funds tracked by Wall St. Rank held Anterix as of Q1 2020.

Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.